Overview
Inositol is a collection of nine different stereoisomers but the name is usually used to describe only the most common type of inositol, myo-inositol. Myo-inositol is the cis-1,2,3,5-trans-4,6-cyclohexanehexol and it is prepared from an aqueous extract of corn kernels by precipitation and hydrolysis of crude phytate. These molecules have structural similarities to glucose and are involved in cellular signaling. It is considered a pseudovitamin as it is a molecule that does not qualify to be an essential vitamin because even though its presence is vital in the body, a deficiency in this molecule does not translate into disease conditions. Inositol can be found as an ingredient of OTC products by Health Canada but all current product whose main ingredient is inositol are discontinued. By the FDA, inositol is considered in the list of specific substances affirmed as generally recognized as safe (GRAS).
Indication
Inositol may be used in food without any limitation. As a drug, inositol is used as a nutrient supplement in special dietary foods and infant formula. As it presents a relevant role in ensuring oocyte fertility, inositol has been studied for its use in the management of polycystic ovaries. Inositol is also being researched for the treatment of diabetes, prevention of metabolic syndrome, aid agent for weight loss, treatment of depression, psychiatric disorder and anxiety disorder and for prevention of cancer.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/06/12 | Phase 2 | Not yet recruiting | |||
2022/06/08 | N/A | Completed | University of Bari Aldo Moro | ||
2021/05/19 | Not Applicable | Completed | |||
2020/03/13 | Phase 4 | Terminated | |||
2020/02/18 | Phase 2 | UNKNOWN | |||
2019/12/18 | Early Phase 1 | UNKNOWN | Rashid Latif Medical College | ||
2019/03/06 | Phase 2 | Recruiting | |||
2018/12/06 | Phase 3 | UNKNOWN | |||
2017/06/06 | Phase 4 | Recruiting | |||
2016/06/23 | Phase 1 | Withdrawn | Ronald M. Glick, MD |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| Super B Complex tablets | 126510 | Medicine | A | 3/28/2006 | |
| Wealthy Health Bio-Maxi B Excellent Stress Relief Formula with Herbs | 139048 | Medicine | A | 5/21/2007 | |
| Caruso's Hair Food | 130857 | Medicine | A | 8/30/2006 | |
| Threshold Controlled B-Complex | 276600 | Medicine | A | 6/15/2016 | |
| Mediherb P2-Detox | 218993 | Medicine | A | 1/8/2014 | |
| Swisse Ultiboost Magnesium + Sleep Powder | 313001 | Medicine | A | 1/8/2019 | |
| MUSASHI SLEEP RECOVERY | 308710 | Medicine | A | 8/28/2018 | |
| NuroBalance Forte | 307546 | Medicine | A | 7/30/2018 | |
| BLACKMORES EXECUTIVE B (Export - ID) | 346930 | Medicine | A | 11/2/2020 | |
| InNatal | 346421 | Medicine | A | 10/22/2020 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| STRESS B CAPSULES WITH VITAMIN C | rheingold food international ltd. | 00694509 | Capsule - Oral | 25 MG / CAP | 12/31/1987 |
| STRESS B WITH 1000 MG VITAMIN C | holista health (canada) inc. | 02246252 | Tablet - Oral | 25 MG | 11/13/2002 |
| STRESS B PLUS VITAMINS & MINERALS | great earth companies, inc. | 02231749 | Tablet (Extended-Release) - Oral | 160 MG / TAB | 9/25/1998 |
| LIQUI B COMPLEX PLUS | twin laboratories inc. | 01984411 | Liquid - Oral | 10 MG / ML | 12/31/1995 |
| MATERNITY ONE MULTIVITAMIN WITH MINS CAPLET | swiss herbal remedies ltd. | 01918052 | Tablet - Oral | 25 MG | 12/31/1991 |
| MULTI-REGIME | regime industries ltd. | 02247272 | Capsule - Oral | 7.5 MG | 6/16/2003 |
| MULTI-FORCE FOR ADULTS TAB | bioforce canada inc. | 02009439 | Tablet - Oral | 25 MG / TAB | 12/31/1994 |
| TWIN PRO POWDER VANILLA | twin laboratories inc. | 02014149 | Powder - Oral | 25 MG / 71.35 G | 12/31/1995 |
| ONE PER DAY OMNIPLEX WITH BETA CAROTENE-TAB | vita health products inc | 02135795 | Tablet - Oral | 15 MG | 10/11/1996 |
| WOMEN'S 45+ | natural factors nutritional products ltd. | 02244128 | Tablet - Oral | 16.7 MG | 12/19/2001 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| DERTRASE POMADA | Laboratorios Salvat S.A. | 32935 | POMADA | Medicamento Sujeto A Prescripción Médica | Not Commercialized |
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.